178 related articles for article (PubMed ID: 25223913)
1. TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
Zhang W
Chin J Cancer; 2014 Oct; 33(10):469-70. PubMed ID: 25223913
[TBL] [Abstract][Full Text] [Related]
2. Actionable gene-based classification toward precision medicine in gastric cancer.
Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.
Sunakawa Y; Lenz HJ
Curr Treat Options Oncol; 2015 Apr; 16(4):17. PubMed ID: 25813036
[TBL] [Abstract][Full Text] [Related]
4. The journey of personalizing gastric cancer treatment.
Yan L
Chin J Cancer; 2016 Aug; 35(1):84. PubMed ID: 27581614
[TBL] [Abstract][Full Text] [Related]
5. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
Yuen ST; Leung SY
Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of gastric cancer.
Chia NY; Tan P
Ann Oncol; 2016 May; 27(5):763-9. PubMed ID: 26861606
[TBL] [Abstract][Full Text] [Related]
7. Comparison and applicability of molecular classifications for gastric cancer.
Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
[TBL] [Abstract][Full Text] [Related]
8. Dissection of gastric cancer heterogeneity for precision oncology.
Ho SWT; Tan P
Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
Gullo I; Carneiro F; Oliveira C; Almeida GM
Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
[TBL] [Abstract][Full Text] [Related]
10. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
Corso S; Giordano S
Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
[TBL] [Abstract][Full Text] [Related]
11. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
12. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.
Tan P; Yeoh KG
Gastroenterology; 2015 Oct; 149(5):1153-1162.e3. PubMed ID: 26073375
[TBL] [Abstract][Full Text] [Related]
13. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Choi YY; Cheong JH
Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
[TBL] [Abstract][Full Text] [Related]
14. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
15. Genomic pathobiology of gastric carcinoma.
Katoh H; Ishikawa S
Pathol Int; 2017 Feb; 67(2):63-71. PubMed ID: 28004449
[TBL] [Abstract][Full Text] [Related]
16. Progress of Gastric Cancer Surgery in the era of Precision Medicine.
Wang Y; Zhang L; Yang Y; Lu S; Chen H
Int J Biol Sci; 2021; 17(4):1041-1049. PubMed ID: 33867827
[TBL] [Abstract][Full Text] [Related]
17. Dawn of precision medicine on gastric cancer.
Ishii T; Kawazoe A; Shitara K
Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
[TBL] [Abstract][Full Text] [Related]
18. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
Yoon JY; Sy K; Brezden-Masley C; Streutker CJ
PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of gastric cancer.
Röcken C
Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
[TBL] [Abstract][Full Text] [Related]
20. Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Pectasides E
Clin Ther; 2016 Jul; 38(7):1589-99. PubMed ID: 27041412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
